annb0t
Top 20
Mesoblast (ASX:MSB) Second Quarter 2023 Results
Key Financial Results
Net loss: US$24.5m (loss narrowed by 5.6% from 2Q 2022). US$0.033 loss per share (improved from US$0.04 loss in 2Q 2022). earnings-and-revenue-growth
All figures shown in the chart above are for the trailing 12 month (TTM) period
Mesoblast EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 6.8%. Earnings per share (EPS) exceeded analyst estimates by 11%.
Looking ahead, revenue is forecast to ...
>>> Read more: Mesoblast Second Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag
Key Financial Results
Net loss: US$24.5m (loss narrowed by 5.6% from 2Q 2022). US$0.033 loss per share (improved from US$0.04 loss in 2Q 2022). earnings-and-revenue-growth
All figures shown in the chart above are for the trailing 12 month (TTM) period
Mesoblast EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 6.8%. Earnings per share (EPS) exceeded analyst estimates by 11%.
Looking ahead, revenue is forecast to ...
>>> Read more: Mesoblast Second Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag
